TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Piyanuch Kongtim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.